Innovations improving peptide stability and half-life, extending therapeutic efficacy and reducing dosing frequency.
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 04, 2024 (GLOBE NEWSWIRE) — The global peptide therapeutics market (ペプチド治療薬市場) is estimated to thrive at a CAGR of 9.6% from 2023 to 2031. Transparency Market Research projects that the overall sales revenue for peptide therapeutics is estimated to reach US$ 85.9 billion by the end of 2031.
Emerging research suggests the role of microbiome-targeted peptides in modulating gut microbiota and treating various diseases. Companies exploring this frontier are likely to drive market growth by tapping into the therapeutic potential of microbiome-based peptides.
The shift towards precision medicine, driven by advances in genomics and biomarker identification, is creating opportunities for personalized peptide therapeutics tailored to individual patient profiles. This approach maximizes treatment efficacy while minimizing adverse effects, driving demand for custom peptide formulations.
The development of peptide-based vaccines targeting infectious diseases, cancer, and autoimmune disorders is gaining traction. With advantages such as safety, specificity, and ease of manufacturing, peptide vaccines hold promise for preventing and treating a wide range of illnesses, fueling market expansion.
For More Details, Request for a Sample of this Research Report: https://www.transparencymarketresearch.com/peptide-therapeutics-market.html
Novel drug delivery systems, including nanoparticles, liposomes, and microneedle patches, are revolutionizing peptide administration, enhancing bioavailability and patient compliance. Companies investing in innovative delivery technologies are poised to gain a competitive edge and drive market growth.
The focus on orphan and rare diseases presents opportunities for developing niche peptide therapeutics addressing unmet medical needs. With streamlined regulatory pathways and incentives, companies targeting rare diseases can accelerate drug development and commercialization, contributing to market expansion.
Peptide Therapeutics Market: Competitive Landscape
In the dynamic landscape of the PEPTIDE THERAPEUTICS MARKET, several key players vie for dominance. Leading pharmaceutical companies such as Novo Nordisk, Eli Lilly and Company, and AstraZeneca hold substantial market shares, leveraging their extensive R&D capabilities and diversified portfolios.
Innovative biotech firms like Amgen, Inc., and Ipsen SA are disrupting the market with novel peptide-based therapies. The market also witnesses fierce competition from emerging players focusing on niche therapeutic areas.
Factors such as technological advancements, regulatory approvals, and strategic collaborations shape the competitive environment, driving companies to continuously innovate and expand their market presence in this burgeoning sector. Some prominent players are as follows:
- Amgen Inc.
- Sachem Holding AG
- Eli Lilly and Company
- Hoffmann-La Roche Ltd.
- GlaxoSmithKline
- Novartis AG
- Pfizer Inc.
- Sanofi
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
Product Portfolio
- Amgen pioneers transformative medicines, focusing on serious illnesses. Their portfolio includes innovative biologics and biosimilars, addressing unmet medical needs globally.
- Sachem Holding AG is a leader in specialty chemicals, offering cutting-edge solutions for various industries. Their diverse portfolio caters to a range of applications, ensuring reliability and performance.
- Eli Lilly and Company is committed to advancing healthcare through breakthrough pharmaceuticals. With a focus on research and innovation, their portfolio encompasses a wide range of therapeutic areas, enhancing patient outcomes worldwide.
Key Findings of the Market Report
- Innovative peptide therapeutics leads the market, driven by continuous research and development efforts to address unmet medical needs effectively.
- Oncology emerges as the leading application segment in the Peptide Therapeutics Market, driven by the increasing demand for targeted cancer therapies.
- Analog Peptides lead the Peptide Therapeutics Market, offering enhanced therapeutic properties and improved pharmacokinetics compared to native peptides.
For Complete Report Details, Request Sample Copy from Here- https://www.transparencymarketresearch.com/peptide-therapeutics-market.html
Peptide Therapeutics Market Growth Drivers & Trends
- Increasing prevalence of chronic diseases drives demand for targeted and personalized therapies, propelling growth in the peptide therapeutics market.
- Advancements in peptide synthesis and delivery technologies enhance efficacy and expand treatment options.
- Rising investments in biopharmaceutical R&D foster innovation and pipeline expansion for peptide-based drugs.
- Growing acceptance of biologics and biosimilars fuels adoption of peptide therapeutics for various therapeutic applications.
- Strategic collaborations and partnerships between pharmaceutical companies and research institutions accelerate drug development and commercialization in the peptide therapeutics market.
Global Peptide Therapeutics Market: Regional Profile
- In North America, particularly the United States, the market is propelled by robust healthcare infrastructure, significant R&D investments, and a high prevalence of chronic diseases. Key players such as Eli Lilly and Company and Amgen Inc., drive innovation, supported by favorable regulatory frameworks fostering drug development and commercialization.
- Europe boasts a mature market for peptide therapeutics, led by countries like Germany, the United Kingdom, and France. Strong emphasis on biopharmaceutical research, coupled with government initiatives promoting healthcare access, fuels market growth. Partnerships between academia and industry foster collaborative research efforts, driving advancements in peptide-based therapies.
- The Asia Pacific region emerges as a rapidly expanding market, propelled by rising healthcare expenditures, increasing patient awareness, and a growing geriatric population.
- Countries like China, Japan, and India witness significant investments in biotechnology and pharmaceutical sectors, facilitating market expansion. Local players and multinational corporations strategically invest in this region to capitalize on its vast market potential and favorable regulatory landscape.
Peptide Therapeutics Market: Key Segments
By Product Type
- Innovative
- Generic
By Application
- Metabolic
- Oncology
- Gastrointestinal
- Cardiovascular
- Neurological
- Others
By Route of Administration
- Parenteral
- Oral
- Others
By Types of Peptide
- Native Peptides
- Analog Peptides
- Heterologous Peptides
By Technology
- Liquid Phase
- Solid phase
- Hybrid
By Manufacturing Type
- In-house
- CMO
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Explore More Trending Report by Transparency Market Research:
Wearable Heart Monitoring Devices Market (웨어러블 심장 모니터링 장치 시장) Size to Hit US$ 5.8 Billion, Globally, by 2031, Expanding at a CAGR of 12.5% Says, Transparency Market Research
Lactate Meter Market (Marché des compteurs de lactate) size was worth USD 141.3 Mn in 2022 and is expected to reach USD 299.5 Mn by 2031 with a CAGR of 8.5%.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
- Golden Triangle Ventures Restructures Over $7M in Legacy Debt, Secures Strategic Investor to Strengthen Capital Table and Accelerate Growth - July 1, 2025
- SIMPPLE Ltd. Announces Results of AGM - July 1, 2025
- Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology™ platform and portfolio - July 1, 2025
